Speaker to be Announced!

Kayla Bourgeois, PharmD
Kayla Bourgeois, PharmD, DABAT, is an Emergency Medicine Pharmacist and Clinical Toxicologist and faculty member at the University of Maryland School of Pharmacy. She is originally from outside Baton Rouge, Louisiana, and earned her Doctor of Pharmacy degree at the University of Mississippi. She completed a PGY1 residency at the University of Maryland Medical Center followed by a two-year Clinical Toxicology and Emergency Medicine fellowship at SUNY Upstate Medical Center/Binghamton School of Pharmaceutical Sciences. She currently serves as Clinical Toxicology Fellowship Director, practices at the Maryland Poison Center, and provides clinical toxicology education across Maryland and the District of Columbia. Her professional interests include emergency medicine toxicology, poison center operations, and clinical toxicology education.

Timothy B. Erickson, MD, FACEP, FACMT, FAACT
Dr. Erickson is an emergency medicine physician at Mass General Brigham in Boston, MA. He is the Division Chief of Medical Toxicology in the Department of Emergency Medicine. He is a Full Professor at Harvard Medical School and the Harvard Humanitarian Initiative (HHI). He is a Professor Emeritus at the University of Illinois where he established the UIC Center for Global Health. His areas of expertise include CBRNE response and training, environmental toxicology, crisis in climate change, wastewater epidemiology, and acute injuries from global conflict settings such as Ukraine, Syria, Kosovo, Sudan, and Rwanda. Over the past 3 decades he had conducted numerous projects and deployments to Ukraine with NATO and International Medical Corps (IMC).

12:00 – 1:00 PM CT
Bayer Sponsored Session

Speaker to be Announced!

Awardee to be Announced!

Katherine Isoardi, MD
Associate Professor Katherine Isoardi is a Clinical Toxicologist, Emergency Physician, and clinician researcher based at the Princess Alexandra Hospital in Brisbane. She leads innovative models of toxicology care, including the expansion of a Virtual Toxicology Service across Queensland, improving access to specialist poisoning management. Katherine completed her PhD in 2025 and has a strong research focus on antidotes, opioid toxicity, envenomation, and health service delivery. Her work has contributed to practice-changing advances in toxicology, including abbreviated acetylcysteine regimens and naloxone dosing strategies. She is passionate about translating research into clinical practice, education, and improving outcomes for poisoned patients.

Angela Chiew
More information coming soon!

Amanda Holford
More information coming soon!

Sandra Comer, PhD
Dr. Sandra Comer is a Professor of Neurobiology in the Department of Psychiatry at Columbia University. She received her BS at Vanderbilt University and PhD at the University of Michigan for her research on the effects of drugs using preclinical models. Her current research focus is on the clinical testing of medications for treating opioid use disorder, methods to maximize the use of naloxone by opioid users, and evaluations of the comparative abuse liability of prescribed pain medications. Dr. Comer served as President of the College on Problems of Drug Dependence, the longest standing scholarly society in the U.S. devoted to research on substance use disorders, and currently is the Public Policy Officer for CPDD. She joined the Expert Advisory Panel on Drug Dependence for the WHO and has over 150 publications on substance use disorders.

APAMT | Speaker To be Announced

EAPCCT | EPITOX | Speaker to be Announced

MENATOX | Speaker to be Announced

Organization to be Announced | Speaker to be Announced

Speaker to be Announced!